1. ZHAW digitalcollection
  2. Life Sciences und Facility Management
  3. Publikationen
  4. Publikationen Life Sciences und Facility Management
Full metadata record
DC FieldValueLanguage
dc.contributor.authorSchirmer, Cedric-
dc.contributor.authorNussbaumer, Thomas-
dc.contributor.authorSchöb, Reto-
dc.contributor.authorPörtner, Ralf-
dc.contributor.authorEibl, Dieter-
dc.date.accessioned2022-08-11T12:16:56Z-
dc.date.available2022-08-11T12:16:56Z-
dc.date.issued2019-07-
dc.identifier.urihttps://digitalcollection.zhaw.ch/handle/11475/25413-
dc.description.abstractBiotherapeutics have great potential for the treatment of cancer and autoimmune diseases. They are considered to be the pharmaceuticals of the future. The bioreactor, in which microorganisms or animal cell cultures usually express the product, is the central element of the manufacturing process. Due to their specific morphology, growth and product formation properties, both production organism types have different requirements with regard to energy, gas, heat and oxygen input. In order to meet these requirements, stirred microbial and cell culture bioreactors differ in their geometry and equipment. This also applies to the agitator and the drive, whereby different agitator types or combinations with varying power inputs are used depending on the application. As part of a cooperation project with Levitronix GmbH, a novel bioreactor drive is being developed that can be used both for microorganisms and cell cultures on a benchtop scale. The use of a universal, sealfree, magnetically driven bottom agitator has shown promising results. Due to the contactless agitator, no damaging frictional forces are transferred to the production organisms and the risk of contamination due to a lack of shaft feedthrough is minimised. The magnetic drive is able to meet the different demands on the environmental and cultivation conditions without any effort, modification or use of different bioreactor systems and enables the balancing act between cultivation with low (500 W/m3) up to high power inputs (25 kW/m3). First cultivations with Escherichia coli delivered high cell densities (86.6 g/L dry mass). During the mass propagation of CHO cells (Chinese hamster ovary cells) in a chemically defined minimum medium, the targeted middle cell densities were achieved with viabilities of 95 % on average.de_CH
dc.language.isoende_CH
dc.publisherZHAW Zürcher Hochschule für Angewandte Wissenschaftende_CH
dc.rightsNot specifiedde_CH
dc.subject.ddc660: Technische Chemiede_CH
dc.titleDevelopment of an universally useable single-use bioreactor for the benchtop scalede_CH
dc.typeKonferenz: Posterde_CH
dcterms.typeTextde_CH
zhaw.departementLife Sciences und Facility Managementde_CH
zhaw.organisationalunitInstitut für Chemie und Biotechnologie (ICBT)de_CH
zhaw.conference.detailsBioTech 2019 : Biopharmaceutical Manufacturing and Single-Use Technologies, Wädenswil, Switzerland, 2-4 July 2019de_CH
zhaw.funding.euNode_CH
zhaw.originated.zhawYesde_CH
zhaw.publication.statuspublishedVersionde_CH
zhaw.publication.reviewNot specifiedde_CH
zhaw.webfeedVerfahrenstechnikde_CH
zhaw.author.additionalNode_CH
zhaw.display.portraitYesde_CH
Appears in collections:Publikationen Life Sciences und Facility Management

Files in This Item:
There are no files associated with this item.
Show simple item record
Schirmer, C., Nussbaumer, T., Schöb, R., Pörtner, R., & Eibl, D. (2019, July). Development of an universally useable single-use bioreactor for the benchtop scale. BioTech 2019 : Biopharmaceutical Manufacturing and Single-Use Technologies, Wädenswil, Switzerland, 2-4 July 2019.
Schirmer, C. et al. (2019) ‘Development of an universally useable single-use bioreactor for the benchtop scale’, in BioTech 2019 : Biopharmaceutical Manufacturing and Single-Use Technologies, Wädenswil, Switzerland, 2-4 July 2019. ZHAW Zürcher Hochschule für Angewandte Wissenschaften.
C. Schirmer, T. Nussbaumer, R. Schöb, R. Pörtner, and D. Eibl, “Development of an universally useable single-use bioreactor for the benchtop scale,” in BioTech 2019 : Biopharmaceutical Manufacturing and Single-Use Technologies, Wädenswil, Switzerland, 2-4 July 2019, Jul. 2019.
SCHIRMER, Cedric, Thomas NUSSBAUMER, Reto SCHÖB, Ralf PÖRTNER und Dieter EIBL, 2019. Development of an universally useable single-use bioreactor for the benchtop scale. In: BioTech 2019 : Biopharmaceutical Manufacturing and Single-Use Technologies, Wädenswil, Switzerland, 2-4 July 2019. Conference poster. ZHAW Zürcher Hochschule für Angewandte Wissenschaften. Juli 2019
Schirmer, Cedric, Thomas Nussbaumer, Reto Schöb, Ralf Pörtner, and Dieter Eibl. 2019. “Development of an Universally Useable Single-Use Bioreactor for the Benchtop Scale.” Conference poster. In BioTech 2019 : Biopharmaceutical Manufacturing and Single-Use Technologies, Wädenswil, Switzerland, 2-4 July 2019. ZHAW Zürcher Hochschule für Angewandte Wissenschaften.
Schirmer, Cedric, et al. “Development of an Universally Useable Single-Use Bioreactor for the Benchtop Scale.” BioTech 2019 : Biopharmaceutical Manufacturing and Single-Use Technologies, Wädenswil, Switzerland, 2-4 July 2019, ZHAW Zürcher Hochschule für Angewandte Wissenschaften, 2019.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.